Διεθνείς Δημοσιεύσεις

Το επιστημονικό έργο της Δρ. Σοφίας Μπάκα (έως τον 10/2025) παρουσιάζεται διεθνώς σε:

• Περισσότερες από 20 αναφορές στα καλύτερα impact factors του κόσμου (Lancet, New Engl Med) και σε περιοδικά για κλινικές μελέτες
• 75 papers (εκτός κλινικών μελετών) σε σημαντικά επιστημονικά περιοδικά

LANCET (IF 88.5)

1. Barlesi F, Yao W, Duruisseaux M, Doucet L, et al KRYSTAL-12 Investigators. Adagrasib versus docetaxel in KRAS^G12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.

Lancet. 2025 Aug 9;406(10503):615-626.

doi: 10.1016/S0140-6736(25)00866-9. PMID: 40783289.

2. Paz-Ares L, Borghaei H, Liu SV, Peters S, Herbst RS, Stencel K, Majem M, Şendur MAN, Czyżewicz G, Caro RB, Lee KH, Johnson ML, Karadurmuş N, Baka S, Csőszi IMforte investigators. Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.

Lancet. 2025 Jun 14;405(10495):2129-2143. doi: 10.1016/S0140-6736(25)01011-6. Epub 2025 Jun 2. PMID: 40473449.

N Engl J Med   (IF 78.8)

1. Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, DeLLphi-304 Investigators. Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.

N Engl J Med. 2025 Jul 24;393(4):349-361. doi: 10.1056/NEJMoa2502099. Epub 2025 Jun 2. PMID: 40454646.

2. Forde PM, Spicer JD, Provencio M, Mitsudomi T, et al CheckMate 816 Investigators. Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.

N Engl J Med. 2025 Aug 21;393(8):741-752. doi: 10.1056/NEJMoa2502931. Epub 2025 Jun 2. PMID: 40454642.

3. Jhaveri KL, Neven P, Casalnuovo ML, et al EMBER-3 Study Group. Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.

N Engl J Med. 2025 Mar 27;392(12):1189-1202. doi: 10.1056/NEJMoa2410858. Epub 2024 Dec 11. PMID: 39660834.

4. Hadoux J, Elisei R, Brose MS, et al LIBRETTO-531 Trial Investigators. Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer.

N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. PMID: 37870969.

5. Loriot Y, Matsubara N, Park SH, et al THOR Cohort 1 Investigators. Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.

N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. PMID: 37870920.

6. Modi S, Jacot W, Yamashita T et al DESTINY-Breast04 Trial Investigators. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. PMID: 35665782; PMCID: PMC10561652.

7. Forde PM, Spicer J, Lu S, Provencio M, et al CheckMate 816 Investigators. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.

N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. PMID: 35403841; PMCID: PMC9844511.

8. Motzer R, Alekseev B, Rha SY, et al CLEAR Trial Investigators. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. PMID: 33616314.

10  PAPERS  

Motzer RJ, Porta C, Eto M, et al CLEAR Trial Investigators.  Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. PMID: 38227898; PMCID: PMC11095851.

Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Barrios CH, Greillier L, Baka S, Patel M, Lin WH, Selvaggi G, Baudelet C, Baden J, Pandya D, Doshi P, Kim HR.  Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.

J Clin Oncol. 2021 Apr 20;39(12):1349-1359. doi: 10.1200/JCO.20.02212. Epub 2021 Mar 8. PMID: 33683919; PMCID: PMC8078251.

Leighl NB, Paz-Ares L, Abreu DR, Hui R, Baka S, Bigot F, Nishio M, et al LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy.

J Thorac Oncol. 2025 Jun 3:S1556-0864(25)00750-6.doi: 10.1016/j.jtho.2025.05.020. Epub ahead of print. PMID: 40473109.

Paz-Ares L, Goto Y, Wan-Teck Lim D, Halmos B, Chul Cho B, Cobo M, Luis González Larriba J, Zhou C, Atmaca A, Baka S, Reck M.  Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial.

Lung Cancer. 2024 Mar;189:107451. doi: 10.1016/j.lungcan.2023.107451. Epub 2024 Jan 16. PMID: 38354535.

Siefker-Radtke AO, Matsubara N, Park SH, et al THOR cohort 2 investigators. Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.

Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003.

Epub 2023 Oct 21. PMID: 37871702.

Mountzios G, Koumarianou A, Linardou H, Boutis A, Mavroudis D, Samantas E, Lampaki S, Georgoulias V, Baka S, Karamouzis MV,

Clinical Outcomes Beyond 1L <i>EGFR</i>-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’.

Anticancer Res. 2023 May;43(5):2243-2258. doi: 10.21873/anticanres.16388. PMID: 37097667.

Lampaki S, Mountzios G, Georgoulias V, Rapti A, Xanthakis I, Baka S, et al Real-world management patterns in <i>EGFR</i>-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.

Future Oncol. 2022 Sep;18(28):3151-3164. doi: 10.2217/fon-2022-0386. Epub 2022 Aug 5. PMID: 35929414.

Koumarianou A, Makrantonakis P, Zagouri F, Papadimitriou C, Christopoulou A,

Samantas E, Christodoulou C, Psyrri A, Bafaloukos D, Aravantinos G, Papakotoulas

P, Baka S, et al  ABREAST: a prospective, real-world study on the effect

of nab-paclitaxel treatment on clinical outcomes and quality of life of patients

with metastatic breast cancer.

Bafaloukos D, Kouzis P, Gouveris P, Boukovinas I, Kalbakis K, Baka S, et al Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The ‘SUMMER’ study: a retrospective multicenter chart review project.

Melanoma Res. 2024 Apr 1;34(2):152-165. doi: 10.1097/CMR.0000000000000949. Epub 2023 Dec 13. PMID: 38092014; PMCID: PMC10906211.PMC6987995.

Alexopoulos A, Karanikiotis C, Ardavanis A, Boukovinas I, Makrantonakis P,

Papadimitriou C, Athanasiadis A, Boutis A, Giassas S, Kakolyris S, Koumakis G,

Papazisis K, Psyrri A, Ziras N, Baka S, Kentepozidis N, Michalaki V. Safety and

Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive,

HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study).

Anticancer Res. 2022 Feb;42(2):1031-1041. doi: 10.21873/anticanres.15564. PMID: 35093904.

J Cancer      

1. Oikonomidou R, Petridis D, Alexidis P, Matthaios D, Boukovinas I, Perdikouri EI, Baka S, et al “One Shot” Sample Evaluation of 22G, 22G upgraded, 21G and 19G needle for Endobronchial Ultrasound-EBUS-TBNA.

J Cancer. 2022 Jul 18;13(10):2982-2987. doi: 10.7150/jca.74022. PMID: 36046659; PMCID:PMC9414030.

2. Oikonomidou R, Petridis D, Kosmidis C, Sapalidis K, Hohenforst-Schmidt W, Christakidis V, Petanidis S, Mathaios D, Perdikouri EI, Baka S, et al Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy.

J Cancer. 2022 Aug 8;13(10):3084-3090. doi: 10.7150/jca.75589. PMID: 36046658; PMCID: PMC9414011.

3. Zarogoulidis P, Huang H, Chen W, Petridis D, Matthaios D, Hohenforst-Schmidt W, Tolis C, Tsakiridis K, Baka S, et al Radial Endobronchial Ultrasound for Lung Cancer Diagnosis: Tips and Tricks.

J Cancer. 2022 Jan 31;13(4):1307-1312.doi: 10.7150/jca.67113. PMID: 35281877; PMCID: PMC8899369.

4. Tsiouda T, Sardeli C, Porpodis K, Pilikidou M, Apostolidis G, Kyrka K, Miziou A, Kyrka K, Tsingerlioti Z, Papadopoulou S, Heva A, Koulouris C, Giannakidis D, Boniou K, Kesisoglou I, Vagionas A, Kosmidis C, Sevva C, Papazisis G, Goganau AM, Sapalidis K, Tsakiridis K, Tryfon S, Platanas M, Baka S, Zaric B, Perin B, Petanidis S, Zarogoulidis P. Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

J Cancer. 2020 Mar 5;11(11):3407-3415. doi: 10.7150/jca.40196. PMID: 32231747;

PMCID: PMC7097940.

5. Kosmidis C, Sapalidis K, Koletsa T, Kosmidou M, Efthimiadis C, Anthimidis G, Varsamis N, Michalopoulos N, Koulouris C, Atmatzidis S, Liavas L, Strati TM, Koimtzis G, Tsakalidis A, Mantalovas S, Zarampouka K, Florou M, Giannakidis DE, Georgakoudi E, Baka S, Zarogoulidis P, Man YG, Kesisoglou I. Interferon-γ and Colorectal Cancer: an up-to date.

J Cancer. 2018 Jan 1;9(2):232-238. doi: 10.7150/jca.22962. PMID: 29344268; PMCID: PMC5771329.

6. Lampaki S, Lazaridis G, Zarogoulidis K, Kioumis I, Papaiwannou A, Tsirgogianni K, Karavergou A, Tsiouda T, Karavasilis V, Yarmus L, Darwiche K, Freitag L, Sakkas A, Kantzeli A, Baka S, Hohenforst-Schmidt W, Zarogoulidis P. Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer.

J Cancer. 2015 May 7;6(6):568-74. doi: 10.7150/jca.11893. PMID: 26000049; PMCID: PMC4439943.

7. Shi D, Li F, Wang K, Kong C, Huang H, Li Q, Jin F, Hu C, Wang C, Shi H, Hu Z, Dong Y, Ning Y, Tsakiridis K, Sapalidis K, Kosmidis C, Vagionas A, Hohenforst-Schmidt W, Freitag L, Turner JF, Drevelegas K, Perdikouri EI, Kovacevic T, Sarcev T, Zaric B, Petanidis S, Baka S, Boukovinas I, Kakolyris S, Zarogoulidis P, Bai C. The development of bronchoscopy in China: a national cross-sectional study.

J Cancer. 2020 Jul 20;11(19):5547-5555. doi:10.7150/jca.47183. PMID: 32913450; PMCID: PMC7477436.

8. Domvri K, Bougiouklis D, Zarogoulidis P, Porpodis K, Xristoforidis M, Liaka A, Eleutheriadou E, Lampaki S, Lazaridis G, Organtzis J, Kyriazis G, Hohenforst- Schmidt W, Tsirgogianni K, Karavasilis V, Baka S, Darwiche K, Freitag L, Trakada G, Zarogoulidis K. Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?

J Cancer. 2015 Feb 23;6(4):360-6. doi: 10.7150/jca.11308. PMID: 25767606; PMCID: PMC4349876.

9. Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Tsiouda T,Baka S, Yarmus L, Stratakos G, Organtzis J, Pataka A, Tsakiridis K, Karapantzos I, Karapantzou C, Darwiche K, Zissimopoulos A, Pitsiou G, Zarogoulidis K, Man YG, Rittger H. Tyrosine Kinase Inhibitors for the Elderly.

J Cancer. 2016 Mar 21;7(6):687-93. doi: 10.7150/jca.14819. PMID: 27076850; PMCID: PMC4829555.

10. Hohenforst-Schmidt W, Zarogoulidis P, Pitsiou G, Linsmeier B, Tsavlis D, Kioumis I, Papadaki E, Freitag L, Tsiouda T, Turner JF, Browning R, Simoff M, Sachpekidis N, Tsakiridis K, Zaric B, Yarmus L, Baka S, Stratakos G, Rittger H. Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

J Cancer. 2016 Jan 13;7(4):377-90. doi: 10.7150/jca.13611. PMID: 26918052; PMCID: PMC4749359.

11. Hohenforst-Schmidt W, Zarogoulidis P, Steinheimer M, Benhassen N, Tsiouda T,Baka S, et al Tyrosine Kinase Inhibitors for the Elderly.

J Cancer. 2016 Mar 21;7(6):687-93. doi: 10.7150/jca.14819. PMID: 27076850; PMCID: PMC4829555.

12. Hohenforst-Schmidt W, Zarogoulidis P, Pitsiou G, Linsmeier B, Tsavlis D, Kioumis I, Papadaki E, Freitag L, Tsiouda T, Turner JF, Browning R, Simoff M, Sachpekidis N, Tsakiridis K, Zaric B, Yarmus L, Baka S, Stratakos G, Rittger H. Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

J Cancer. 2016 Jan 13;7(4):377-90. doi: 10.7150/jca.13611. PMID: 26918052; PMCID: PMC4749359.

13. Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, Kosmidis E, Vogl T, Linsmeier B, Tsakiridis K, Lampaki S, Lazaridis G, Mpakas A, Browning R, Papaiwannou A, Drevelegas A, Baka S. Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.

J Cancer. 2015 Jan 16;6(3):218-26. doi: 10.7150/jca.10970. PMID: 25663938; PMCID: PMC4317756.

Ann Transl Med      

1. Tryfon S, Zarogoulidis P, Tsavlis D, Tsirgogianni K, Zissimopoulos A, Kioumis I, Emmanouilides C, Baka S, Titopoulos H, Dager A, Filippou D. Ex situ reimplantation technique, in central lung tumors.

Ann Transl Med. 2015 Aug;3(13):178. doi: 10.3978/j.issn.2305-5839.2015.08.03. PMID: 26366395; PMCID: PMC4543329.

2. Baltayiannis N, Michail C, Lazaridis G, Anagnostopoulos D, Baka S, et al Minimally invasive procedures.

Ann Transl Med. 2015 Mar;3(4):55. doi: 10.3978/j.issn.2305-5839.2015.03.24. PMID: 25861610; PMCID: PMC4381469.

3. Gogakos A, Barbetakis N, Lazaridis G, Papaiwannou A, Karavergou A, Lampaki S, Baka S, et al Heimlich valve and pneumothorax.

Ann Transl Med. 2015 Mar;3(4):54. doi: 10.3978/j.issn.2305-5839.2015.03.25. PMID: 25861609; PMCID: PMC4381465.

4. Kosmidis C, Sapalidis K, Kotidis E, Mixalopoulos N, Zarogoulidis P, Baka S, Man YG, Kanellos J. Pancreatic cancer from bench to bedside: molecular pathways and treatment options

Ann Transl Med. 2016 May;4(9):165. doi: 10.21037/atm.2016.05.11. PMID: 27275478; PMCID: PMC4876273.

5. Papagiannis A, Lazaridis G, Zarogoulidis K, Papaiwannou A, Karavergou A, Lampaki S, Baka S, et al Pneumothorax: an up to date “introduction”.

Ann Transl Med. 2015 Mar;3(4):53. doi: 10.3978/j.issn.2305-5839.2015.03.23.

PMID: 25861608; PMCID: PMC4381472.

6. Zisis C, Tsirgogianni K, Lazaridis G, Lampaki S, Baka S, et al Chest drainage systems in use.

Ann Transl Med. 2015 Mar;3(3):43. doi: 10.3978/j.issn.2305-5839.2015.02.09. PMID: 25815304; PMCID: PMC4356865.

7. Kotsakou M, Kioumis I, Lazaridis G, Pitsiou G, Lampaki S, Papaiwannou A, Karavergou A, Tsakiridis K, Karapantzos I, Karapantzou C, Baka S, et al Pacemaker insertion.

Ann Transl Med. 2015 Mar;3(3):42. doi: 10.3978/j.issn.2305-5839.2015.02.06. PMID: 25815303; PMCID: PMC4356861.

8. Zarogoulidis K, Papaiwannou A, Lazaridis G, Karavergou A, Lampaki S, Baka S et al Pneumothorax from diagnosis to treatment, hands on course: Part II.

Ann Transl Med. 2015 Mar;3(3):41. doi: 10.3978/j.issn.2305-5839.2015.02.10.

PMID: 25815302; PMCID: PMC4356858.

9. Tsotsolis N, Tsirgogianni K, Kioumis I, Pitsiou G, Baka S, et al Pneumothorax as a complication of central venous catheter insertion.

Ann Transl Med. 2015 Mar;3(3):40. doi: 10.3978/j.issn.2305-5839.2015.02.11. PMID: 25815301; PMCID: PMC4356862

10. Charalampidis C, Lampaki S, Zarogoulidis P, Lazaridis G, Mpaka S, et al Fine-needle aspiration of skin metastasis in ovarian cancer-report of two cases and review of the literature.

Ann Transl Med. 2016 Nov;4(22):447. doi: 10.21037/atm.2016.11.02. PMID: 27999781; PMCID: PMC5159411.

11. Sreter KB, Jakopovic M, Janevski Z, Samarzija M, Zarogoulidis P, Kioumis I, Mparmpetakis N, Pataka A, Zarogoulidis K, Tsiouda T, Kosmidis C, Mpaka S, et al A pilot study-is there a role for mitoxantrone pleurodesis in the management of pleural effusion due to lung cancer?

Ann Transl Med. 2016 May;4(9):162. doi: 10.21037/atm.2016.04.15. PMID: 27275475; PMCID: PMC4876260.

12. Kuhajda I, Durić D, Koledin M, Ilic M, Tsavlis D, Kioumis I, Tsirgogianni K, Zarogoulidis K, Organtzis J, Kosmidis C, Baka S, et al Electric vs. harmonic scalpel in treatment of primary focal hyperhidrosis with thoracoscopic sympathectomy.

Ann Transl Med. 2015 Sep;3(15):211. doi: 10.3978/j.issn.2305-5839.2015.09.01. PMID: 26488007; PMCID: PMC4583601.

Cancer      

1. Zarogoulidis P, Hohenforst-Schmidt W, Huang H, Zhou J, Wang Q, Wang X, Xia Y, Ding Y, Bai C, Kosmidis C, Sapalidis K, Sardeli C, Tsakiridis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Baka S, Athanasiou E Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G. J

Cancer. 2021 Mar 5;12(9):2560-2569. doi: 10.7150/jca.55322. PMID: 33854617;

PMCID: PMC8040712.

2. Zarogoulidis P, Petridis D, Sapalidis K, Tsakiridis K, Baka S, et al Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA. J

Cancer. 2020 Sep 14;11(21):6454-6459. doi: 10.7150/jca.48691. PMID: 33033529;

PMCID: PMC7532516.

J Thorac Dis    

1. Kolettas A, Lazaridis G, Baka S, et al Postoperative pain management.

J Thorac Dis. 2015 Feb;7(Suppl 1):S62-72. doi: 10.3978/j.issn.2072-1439.2015.01.15. PMID: 25774311; PMCID: PMC4332101.

2. Paliouras D, Barbetakis N, Lazaridis G, Baka S, et al Video-assisted thoracic surgery and pneumothorax.

J Thorac Dis.2015 Feb;7(Suppl 1):S56-61. doi: 10.3978/j.issn.2072-1439.2015.01.35. PMID: 25774310; PMCID: PMC4332100.

3. Lazopoulos A, Barbetakis N, Lazaridis G, Baka S, et al Open thoracotomy for pneumothorax.

J Thorac Dis. 2015 Feb;7(Suppl 1):S50-5. doi:10.3978/j.issn.2072-1439.2015.01.52. PMID: 25774309; PMCID: PMC4332106.

4. Kouritas VK, Papagiannopoulos K, Lazaridis G, Baka S, et al

Pneumomediastinum. J Thorac Dis. 2015 Feb;7(Suppl 1):S44-9. doi: 10.3978/j.issn.2072-1439.2015.01.11. PMID: 25774307; PMCID: PMC4332083.

5. Ioannidis G, Lazaridis G, Baka S, et al Barotrauma andpneumothorax.

J Thorac Dis. 2015 Feb;7(Suppl 1):S38-43. doi: 10.3978/j.issn.2072-1439.2015.01.31. PMID: 25774306; PMCID: PMC4332090.

6. Charalampidis C, Youroukou A, Lazaridis G, Baka S, et al Physiology of the pleural space.

J Thorac Dis. 2015 Feb;7(Suppl 1):S33-7. doi: 10.3978/j.issn.2072-1439.2014.12.48. PMID: 25774305; PMCID: PMC4332077.

7. Charalampidis C, Youroukou A, Lazaridis G, Baka S, et al Pleura space anatomy.

J Thorac Dis. 2015 Feb;7(Suppl 1):S27-32. doi: 10.3978/j.issn.2072-1439.2015.01.48. PMID: 25774304; PMCID: PMC4332049.

8. Kalifatidis A, Lazaridis G, Baka S, et al Thoracocentesis: from bench to bed.

J Thorac Dis. 2015 Feb;7(Suppl 1):S1-4. doi: 10.3978/j.issn.2072-1439.2014.12.45. PMID: 25774301; PMCID: PMC4332098.

9. Garas G, Zarogoulidis P, Efthymiou A, Athanasiou T, Tsakiridis K, Mpaka S, Zacharakis E. Spontaneous esophageal rupture as the underlying cause of pneumothorax: early recognition is crucial.

J Thorac Dis. 2014 Dec;6(12):1655-8. doi: 10.3978/j.issn.2072-1439.2014.12.04. PMID: 25589955; PMCID: PMC4283292.

10. Filippou D, Kleontas A, Tentzeris V, Emmanouilides C, Tryfon S, Baka S, Filippou I, Papagiannopoulos K. Extended resections for the treatment of patients with T4 stage IIIA non-small cell lung cancer (NSCLC) (T₄N_0-1M₀) with or without cardiopulmonary bypass: a 15-year two-center experience.

J Thorac Dis. 2019 Dec;11(12):5489-5501. doi: 10.21037/jtd.2019.11.33. PMID: 32030268; PMCID:

Kosmidis CS, Mystakidou CM, Koimtzis G, Papadopoulou E, Theodorou V, Katsios

NI, Georgakoudi E, Sevva C, Charalampous I, Varsamis N, Koulouris C, Michael C,

Papadopoulos K, Anthimidis G, Baka S. Idiopathic Multicentric Castleman Disease

with Cutaneous Manifestation:

Case Report. Medicina (Kaunas). 2022 Sep 5;58(9):1222. doi: 10.3390/medicina58091222. PMID: 36143899; PMCID: PMC9505402.

Papers  άλλων περιοδικών 

Kosmidis CS, Papadopoulou K, Mystakidou CM, Papadopoulou E, Mantalovas S,

Varsamis N, Koulouris C, Theodorou V, Papadopoulos K, Sevva C, Miltiadous P, Petanidis S, Georgakoudi E, Papadopoulou E, Baka S. Melanoma: BRAFi Rechallenge.

Medicina 2023 May 18;59(5):975. doi: 10.3390/medicina59050975. PMID:

37241207; PMCID: PMC10220981.

Ranson M, Hersey P, Thompson D, Beith J, McArthur GA, Haydon A, Davis ID, Kefford RF, Mortimer P, Harris PA, Baka S, Seebaran A, Sabharwal A, Watson AJ, Margison GP, Middleton MR. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.

J Clin Oncol. 2007 Jun 20;25(18):2540-5. doi: 10.1200/JCO.2007.10.8217. PMID: 17577032.

Baka S, Iraklis G, Papadopoulou E. Novel vaccines against lung cancer.

Curr Opin Oncol. 2025 Jan 1;37(1):73-83. doi: 10.1097/CCO.0000000000001102. Epub 2024 Oct 1. PMID: 39352275.

Kosmidis CS, Michael C, Mystakidou CM, Theodorou V, Papadopoulou E,

Papadopoulou K, Koulouris C, Varsamis N, Koimtzis G, Roullia P, Ntager M, Sevva

C, Katsios NI, Charalampous I, Zarampouka K, Baka S. An Easily Missed But Life-

Threatening Diagnosis: A Case Report of Gorlin Syndrome.

Am J Case Rep. 2023 Apr 24;24:e939117. doi: 10.12659/AJCR.939117. PMID: 37093778; PMCID: PMC10141339.

Dimitrakopoulos FI, Mountzios G, Christopoulos P, Papastergiou T, Elshiaty

M, Daniello L, Zervas E, Agelaki S, Samantas E, Nikolaidi A, Athanasiadis I,

Baka S, et al Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with

nivolumab or pembrolizumab: results from a European multicentre study. Ther Adv

Med Oncol. 2022 Sep 8;14:17588359221122728. doi: 10.1177/17588359221122728.

PMID: 36105886; PMCID: PMC9465562.

Breast Cancer Res Treat. 2020 Jul;182(1):85-96. doi: 10.1007/s10549-020-05677-4. Epub 2020 May 16. PMID: 32418045.

Ge X, Huang H, Bai C, Guo X, Kosmidis C, Sapalidis K, Baka S, Tsakiridis K,

Hohenforst-Schmidt W, Freitag L, Vagionas A, Drevelegas K, Zarogoulidis P.

Author Correction: The lengths of trachea and main bronchus in Chinese Shanghai

population.

Sci Rep. 2021 Oct 1;11(1):19917. doi: 10.1038/s41598-021-98467-x.

Erratum for: Sci Rep. 2021 Jan 26;11(1):2168. doi: 10.1038/s41598-021-81744-0.

PMID: 34599230; PMCID: PMC8486748.

Zarogoulidis P, Petridis D, Huang H, Bai C, Hohenforst-Schmidt W, Freitag L, Baka S, Biopsy and re-biopsy for PD-L1 expression in NSCLC. Association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study.

Expert Rev Respir Med. 2021 Nov; 15(11):1483-1491. doi: 10.1080/17476348.2021.1987888. Epub 2021 Oct 12. PMID: 34591723.

Mountzios G, Samantas E, Senghas K, Zervas E, Krisam J, Samitas K, Bozorgmehr F, Kuon J, Agelaki S, Baka S,  et al Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.

ESMO Open. 2021 Oct;6(5):100254. doi: 10.1016/j.esmoop.2021.100254. Epub 2021 Sep 1. PMID: 34481329; PMCID: PMC8417333.

Zarogoulidis P, Sardeli C, Christakidis V, Hohenforst-Schmidt W, Huang H,

Kosmidis C, Vagionas A, Baka S, Tsakiridis K, Perdikouri EI, Romanidis K,

Sapalidis K. PD-L1 and standardized uptake value expression in lung cancer: a

possible connection for efficient early lung cancer treatment.

Biomark Med. 2021 May;15(7):463-466. doi: 10.2217/bmm-2020-0485. Epub 2021 Mar 18. PMID: 33733828.

Ge X, Huang H, Bai C, Guo X, Kosmidis C, Sapalidis K, Baka S, Tsakiridis K,

Hohenforst-Schmidt W, Freitag L, Vagionas A, Drevelegas K, Zarogoulidis P. The

lengths of trachea and main bronchus in Chinese Shanghai population.

Sci Rep. 2021 Jan 26;11(1):2168. doi: 10.1038/s41598-021-81744-0. Erratum in: Sci Rep. 2021 Oct 1;11(1):19917. doi: 10.1038/s41598-021-98467-x. PMID: 33500472; PMCID: PMC7838294.

Zarogoulidis P, Huang H, Zhou J, Ning Y, Yang M, Wang J, Zhang R, Bai C,

Shen X, Huang Z, Petridis D, Kosmidis C, Kosmidou M, Tsakiridis K, Hohenforst-

Schmidt W, Baka S, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T,

Bursac D, Kukic B, Rapti A, Pantea S, Rogoveanu O, Rogoveanu I, Romanidis K,

Kesisoglou I, Ioannidis A, Vagionas A, Sapalidis K. Thyroid cancer diagnosis

with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons.

Expert Rev Med Devices. 2021 Feb;18(2):197-201. doi: 10.1080/17434440.2021.1880891. Epub 2021 Jan 29. PMID: 33482695.

Zarogoulidis P, Christakidis V, Petridis D, Sapalidis K, Kosmidis C, Vagionas A, Perdikouri EI, Hohenforst-Schmidt W, Huang H, Petanidis S, Tsakiridis K, Baka S, et al Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.

Expert Rev Respir Med. 2021 May;15(5):675-679. doi: 10.1080/17476348.2021.1859373. Epub 2020 Dec 31. PMID: 33275458.

Sardeli C, Romanidis K, Oikonomou P, Sapalidis K, Huang H, Bai C, Hohenforst-Schmidt W, Tsakiridis K, Zaric B, Perin B, Ioannidis A, Baka S, Drevelegas K, Kosmidou M, Kosmidis C. Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer.

Respir Med Case Rep. 2020 Oct 25;31:101258. doi: 10.1016/j.rmcr.2020.101258. PMID: 33145157; PMCID:PMC7596337.

Kosmidis C, Varsamis N, Atmatzidis S, Koimtzis G, Mantalovas S, Anthimidis

G, Georgakoudi E, Sevva CD, Zarampouka K, Chourmouzi D, Baka S, Kosmidou M. Total Pancreatectomy with Splenectomy for Multifocal Intraductal Tubulopapillary Neoplasm (ITPN) of the Pancreas Associated with Invasive Component: Report of a Rare Case.

Am J Case Rep. 2020 Jul 10;21:e924760. doi: 10.12659/AJCR.924760. PMID: 32647104; PMCID: PMC7377523.

Kosmidis C, Sapalidis K, Tsakalidis A, Atmatzidis S, Michalopoulos N, Koimtzis G, Karayannopoulou G, Lypiridou S, Varsamis N, Kouklakis G, Baka S, Zarogoulidis P, Kesisoglou I. Management of low rectal gastrointestinal stromal tumor with neoadjuvant therapy and transanal excision: a rare case report and review of the literature.

Int J Gen Med. 2019 Mar 1;12:121-124. doi: 10.2147/IJGM.S193988. PMID: 30881087; PMCID: PMC6402437.

Kosmidis CS, Koimtzis GD, Anthimidis G, Varsamis N, Atmatzidis S, Koskinas

IS, Koletsa T, Zarampouka K, Georgakoudi E, Baka S, Efthimiadis C, Kosmidou MS,

Kouklakis G. Endoscopically Assisted Laparoscopic Gastric Resection for Benign

and Malignant Lesions: A Report of Two Cases.

Am J Case Rep. 2018 Jul 28;19:884-890. doi: 10.12659/AJCR.909387. PMID: 30054452; PMCID: PMC6078009.

Zarogoulidis P, Baka S, Labaki S, Lazaridis G, Trakada G. Targeted Lung

Cancer Treatments and Eye Metastasis.

Med Hypothesis Discov Innov Ophthalmol. 2017 Spring;6(1):10-13. PMID: 28428969; PMCID: PMC5392227.

Kallianos A, Velentza L, Zarogoulidis P, Baka S, Kosmidis C, Labaki S, Lazaridis G, Huang H, Hohenforst-Schmidt W, Trakada G. Progressive dyspnea due to pulmonary carcinoid tumorlets.

Respir Med Case Rep. 2017 Apr 6;21:84-85. doi: 10.1016/j.rmcr.2017.03.024. PMID: 28417065; PMCID: PMC5389108.

Foroulis CN, Kleontas AD, Tagarakis G, Nana C, Alexiou I, Grosomanidis V, Tossios P, Papadaki E, Kioumis I, Baka S, Zarogoulidis P, Anastasiadis K.

Massive chest wall resection and reconstruction for malignant disease.

Onco Targets Ther. 2016 Apr 19;9:2349-58. doi: 10.2147/OTT.S101615. PMID: 27143930; PMCID: PMC4846065.

Zarogoulidis P, Lampaki S, Chinelis P, Lazaridis G, Baka S, Rapti A. Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?

Med Hypothesis Discov Innov Ophthalmol. 2016 Winter;5(4):132-135. PMID: 28293661; PMCID: PMC5346303.

Emmanouilides C, Tryfon S, Baka S, Titopoulos H, Dager A, Filippou D.

Operation for preservation of lung parenchyma in central lung cancer–in vivo

and ex situ reimplantation techniques.

Anticancer Res. 2015 Mar;35(3):1675-81. PMID: 25750327.

Kosmidis C, Efthimiadis C, Anthimidis G, Grigoriou M, Fotiadis P, Vasiliadou

K, Mekras D, Ioannidou G, Baka S, Basdanis G. Laparoscopic low anterior

resection for early rectal cancer.

Tech Coloproctol. 2011 Oct;15 Suppl 1:S75-7. doi: 10.1007/s10151-011-0737-x. PMID: 21901517.

Efthimiadis C, Kosmidis C, Grigoriou M, Anthimidis G, Vasiliadou K, Baka S,

Gerasimidou D, Basdanis G. The stapled hemorrhoidopexy syndrome: a new clinical

entity?

Tech Coloproctol. 2011 Oct;15 Suppl 1:S95-9. doi: 10.1007/s10151-011-0741-1. PMID: 21887569.

Kosmidis C, Efthimiadis C, Anthimidis G, Grigoriou M, Vasiliadou K, Ioannidou G, Makedou F, Baka S. Acral lentiginous melanoma: a case control study and guidelines update.

Case Rep Med. 2011;2011:670581. doi: 10.1155/2011/670581. Epub 2011 Apr 6. PMID: 21541184; PMCID: PMC3085478.

Baka S, Agelaki S, Kotsakis A, Veslemes M, Papakotoulas P, Agelidou M, Agelidou A, Tsaroucha E, Pavlakou G, Gerogianni A, Androulakis N, Vamvakas L, Kalbakis K, Mavroudis D, Georgoulias V. Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first- line treatment in small cell lung cancer. Anticancer Res. 2010 Jul;30(7):3031-8. PMID: 20683051.

Kosmıdis C, Efthimiadis C, Anthimidis G, Grigoriou M, Vasiliadou K, Ioannidou G, Baka S, Fahantidis E. Transperitoneal laparoscopic right radical nephrectomy for renal cell carcinoma and end-stage renal disease: a case report.

Cases J. 2009 Nov 18;2:200. doi: 10.1186/1757-1626-2-200. PMID: 20062705; PMCID: PMC2803865.

Valle JW, Wasan H, Johnson P, Jones E, Dixon L, Swindell R, Baka S et al Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomized phase II study – The UK ABC-01 Study.

Br J Cancer. 2009 Aug 18;101(4):621-7. doi: 10.1038/sj.bjc.6605211. PMID: 19672264; PMCID: PMC2736816.

Baka S, Ekonomopoulou MT, Kosmidis C, Efthimiadis C, Iakovidou-Kritsi Z.

Cytogenetic effects of recombinant interferon-gamma on lymphocytes cultures from

patients with non-small cell lung cancer.

Cancer Genet Cytogenet. 2009 Aug;193(1):38-43. doi: 10.1016/j.cancergencyto.2009.04.004. PMID: 19602462.

Kosmidis C, Efthimiadis C, Levva S, Anthimidis G, Baka S, Grigoriou M, Tzeveleki I, Masmanidou M, Zaramboukas T, Basdanis G. Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor in Meckel’s diverticulum; an unusual association.

World J Surg Oncol. 2009 Mar 23;7:33. doi: 10.1186/1477-7819-7-33. PMID: 19309498; PMCID: PMC2664807.

Baka S, Califano R, Ferraldeschi R, Aschroft L, Thatcher N, Taylor P, Faivre-Finn C, Blackhall F, Lorigan P. Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer. Br J Cancer. 2008 Aug 5;99(3):442-7. doi: 10.1038/sj.bjc.6604480. PMID: 18665190; PMCID: PMC2527803.

Ferraldeschi R, Baka S, Jyoti B, Faivre-Finn C, Thatcher N, Lorigan P.

Modern management of small-cell lung cancer.

Drugs. 2007;67(15):2135-52. doi: 10.2165/00003495-200767150-00003. PMID: 17927281.

Baka S, Clamp AR, Jayson GC. A review of the latest clinical compounds to

inhibit VEGF in pathological angiogenesis. Expert Opin Ther Targets. 2006

Dec;10(6):867-76. doi: 10.1517/14728222.10.6.867. PMID: 17105373.

Baka S, Manegold C, Buchholz E, Schott-von-Römer K, Lorigan P, Nagel S,

Blackhall F, Aschroft L, Thatcher N. Dose-finding study of fixed dose

gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients

with advanced non-small cell lung cancer.

Lung Cancer. 2006 Aug;53(2):165-70. doi: 10.1016/j.lungcan.2006.04.010. Epub 2006 Jun 19. PMID: 16787686.

Booton R, Lorigan P, Anderson H, Baka S, Ashcroft L, Nicolson M, O’Brien M,

Dunlop D, O’Byrne K, Laurence V, Snee M, Dark G, Thatcher N. A phase III trial

of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or

mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell

lung cancer: a randomised multicentre trial of the British Thoracic Oncology

Group (BTOG1).

Ann Oncol. 2006 Jul;17(7):1111-9. doi: 10.1093/annonc/mdl078.

Epub 2006 Apr 7. PMID: 16603599.

Kosmidis P, Fountzilas G, Baka S, Samantas E, Dimopoulos AM, Gogas H, Skarlos D, et al  Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non- operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.

Anticancer Res. 2007 Nov-Dec;27(6C):4391-5. PMID: 18214050.

Kosmidis C, Efthimiadis C, Anthimidis G, Levva S, Ioannidou G, Zaramboukas

T, Emmanouilides C, Baka S, Kosmidou M, Basdanis G, Fachantidis E. Adrenalectomy for solitary adrenal metastasis from colorectal cancer: A case report. Cases J. 2008 Jul 18;1(1):49. doi: 10.1186/1757-1626-1-49. PMID: 18638404; PMCID: PMC2503966.

Zarogoulidis P, Matthaios D, Kosmidis C, Hohenforst-Schmidt W, Tsakiridis K,

Mpaka S, et al Effective early diagnosis for NSCLC: an algorithm.

Expert Rev Respir Med. 2021 Nov;15(11):1437-1445. doi: 10.1080/17476348.2021.1969916. Epub 2021 Aug 23. PMID: 34403620.